AstraZeneca's immunotherapy drug wins key lung cancer approval

LONDON (Reuters) - AstraZeneca's immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors.

Malawi cholera cases pass 500, eight people dead

BLANTYRE (Reuters) - Cholera cases in Malawi have tripled and four more people have died, the Ministry of Health said on Monday, a month after the spread of the disease from Zambia was thought to have been contained.

Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict

(Reuters) - A federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs Sovaldi and Harvoni infringed a patent held by rival Merck & Co Inc.

Shares of Apricus tank after FDA declines to OK erectile dysfunction cream

(Reuters) - The U.S. Food and Drug Administration on Friday declined to approve Apricus Biosciences Inc's Vitaros, a cream to treat erectile dysfunction, for the second time in a decade, sending the company's shares down more than 70 percent before the opening bell.

Novartis readies to auction U.S. generic pills business: sources

(Reuters) - Switzerland's Novartis AG is preparing to auction its U.S. generic pill business, looking to shed a unit that has struggled amid fierce price competition, people familiar with the matter said on Friday.

U.S. faces shortage of developmental and behavioral pediatrics specialists

(Reuters Health) - A shortage of clinicians specializing in pediatric behavioral and developmental disorders is translating into long wait times for new patient appointments amid surging demand, a new study suggests.

Fear of federal law may prevent gun retailers from storing firearms

(Reuters Health) - What if someone who lived with the young man who unleashed one of the deadliest school shootings in U.S. history this week had been concerned that he might harm himself or others and removed his AR-15 rifle from his home?

Hospitalized older adults less often tested for flu

(Reuters Health) - Even though elderly people have the highest rates of hospitalization and death from influenza, a U.S. study suggests that older patients may be less likely to get tested for flu in the hospital.

In-person license renewal may reduce crashes involving people with dementia

Reuters Health - Older adults with dementia may be less likely to get in car crashes when they’re required to renew their driver’s licenses in person, a U.S. study suggests.

Pot Pharm: Booming Canada weed sector plots next-wave medicines

TORONTO (Reuters) - Canopy Growth Corp, one of the world's biggest medical marijuana producers, now wants to take on the world's pharmaceutical giants.

Related Videos

Using seawater and crisp packets to cut CO2 emissions

University of York scientists say 850 million tonnes of carbon dioxide could be mineralised each year by combining sea water, graphite, solar-powered electricity, and scrap metal in a purpose-built reactor. Jim Drury reports.

Catalyst makes alcohol and perfume from air

A US start-up has developed a catalyst and reactor that turns air, sunlight and water into pure ethanol for use in consumer products like alcoholic spirits and perfume. Stuart McDill reports.
Read Reuters on the go

Download the free Reuters News app today for breaking news, analysis and market data from the world's most trusted news organization.

Get the app